Actively Recruiting
Intravenous Contrast Computed Tomography Versus Native Computed Tomography in Patients With Acute Abdomen and Impaired Renal Function
Led by Helsinki University Central Hospital · Updated on 2021-02-02
994
Participants Needed
3
Research Sites
675 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Computer tomography (CT) is the primary imaging option for acute abdominal pain in adults. Intravenous (IV) contrast media is used to improve the CT quality. In patients with impaired renal function, post-contrast acute kidney injury (PC-AKI) has remained a significant concern. Modern retrospective studies have shown no association between worsened baseline renal function and IV-contrast CT. However, no randomised controlled trial has been done to conclude this. The INCARO (INtravenous Contrast computed tomography versus native computed tomography in patients with acute Abdomen and impaired Renal functiOn) trial is a multicentre, open-label, parallel group, superiority, individually randomised controlled trial comparing IV-contrast enhanced CT to native CT in patients with impaired renal function. Patients requiring emergency abdominal or body CT with eGFR 15-45 ml/min/1.73 m2 are included in the study. The primary outcome is a composite outcome of all-cause mortality or renal replacement therapy within 90 days from CT.
CONDITIONS
Official Title
Intravenous Contrast Computed Tomography Versus Native Computed Tomography in Patients With Acute Abdomen and Impaired Renal Function
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients requiring emergency abdominal or body CT with eGFR 15-45 ml/min/1.73 m2
You will not qualify if you...
- Age less than 18 years
- Pregnancy
- eGFR less than 15 or more than 45 ml/min/1.73 m2
- Renal replacement therapy within 30 days prior enrolment
- CT with IV contrast less than 72 hours prior enrolment
- Suspicion of vascular occlusion, dissection or bleeding (need for IV-contrast)
- CT needed without IV-contrast to detect or rule out ureteral stone
- IV contrast allergy
- Inability to give written consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Jorvi hospital, Helsinki University Hospital
Espoo, Finland, 00029
Actively Recruiting
2
Meilahti hospital, Helsinki University Hospital
Helsinki, Finland, 00029
Actively Recruiting
3
Hyvinkää hospital
Hyvinkää, Finland, 00029
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here